Pfizer Inc. is looking to sell its remaining stake in Covid-19 vaccine partner BioNTech SE, a remnant from one of the pandemic’s most lucrative collaborations.
Pfizer Inc said on Thursday it sold a part of its stake in German drugmaker BioNTech SE , more than five years after both ...
Shah Capital, Novavax's second-largest shareholder, is pressing the biotech's board to pursue strategic changes, including a ...
Pfizer sell 508M stake in BioNTech through an overnight block trade, marking its exit from the COVID-19 vaccine partner's equity.
The LDS Church's stock investments at Ensign Peak Advisors have climbed to a new high in value at $60.9 billion. That's ...
The US drugmaker is offering about 4.55 million American depositary receipts via an overnight block trade marketed between ...
A BioNTech spokesperson downplayed the news, insisting that the two companies remain “close” and have a “strong collaboration ...
Stocktwits on MSN
BioNTech Says Collaboration With Pfizer Going Strong After Report Indicated US Pharma Giant Considering Stake Sale In The German Company
The clarification from the German biotech company comes on the heels of a Bloomberg report that Pfizer is considering selling ...
Here are some things to know about the tariffs arguments at the Supreme Court: They are paid by companies that import ...
New data the Agriculture Department released Friday created serious doubts about whether China will really buy millions of ...
The S&P 500, Nasdaq Composite, and Dow Jones Industrial Average have all hit new highs in 2025 -- and even the federal government is benefiting from it. President Trump's administration has taken ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback